Towards the disease biomarker in an individual patient using statistical health monitoring.
In metabolomics, identification of complex diseases is often based on application of (multivariate) statistical techniques to the data. Commonly, each disease requires its own specific diagnostic model, separating healthy and diseased individuals, which is not very practical in a diagnostic setting....
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3972152?pdf=render |
id |
doaj-e3cd6b99283d43dd86c430bc6221af08 |
---|---|
record_format |
Article |
spelling |
doaj-e3cd6b99283d43dd86c430bc6221af082020-11-24T21:50:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0194e9245210.1371/journal.pone.0092452Towards the disease biomarker in an individual patient using statistical health monitoring.Jasper EngelLionel BlanchetUdo F H EngelkeRon A WeversLutgarde M C BuydensIn metabolomics, identification of complex diseases is often based on application of (multivariate) statistical techniques to the data. Commonly, each disease requires its own specific diagnostic model, separating healthy and diseased individuals, which is not very practical in a diagnostic setting. Additionally, for orphan diseases such models cannot be constructed due to a lack of available data. An alternative approach adapted from industrial process control is proposed in this study: statistical health monitoring (SHM). In SHM the metabolic profile of an individual is compared to that of healthy people in a multivariate manner. Abnormal metabolite concentrations, or abnormal patterns of concentrations, are indicated by the method. Subsequently, this biomarker can be used for diagnosis. A tremendous advantage here is that only data of healthy people is required to construct the model. The method is applicable in current-population based -clinical practice as well as in personalized health applications. In this study, SHM was successfully applied for diagnosis of several orphan diseases as well as detection of metabotypic abnormalities related to diet and drug intake.http://europepmc.org/articles/PMC3972152?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jasper Engel Lionel Blanchet Udo F H Engelke Ron A Wevers Lutgarde M C Buydens |
spellingShingle |
Jasper Engel Lionel Blanchet Udo F H Engelke Ron A Wevers Lutgarde M C Buydens Towards the disease biomarker in an individual patient using statistical health monitoring. PLoS ONE |
author_facet |
Jasper Engel Lionel Blanchet Udo F H Engelke Ron A Wevers Lutgarde M C Buydens |
author_sort |
Jasper Engel |
title |
Towards the disease biomarker in an individual patient using statistical health monitoring. |
title_short |
Towards the disease biomarker in an individual patient using statistical health monitoring. |
title_full |
Towards the disease biomarker in an individual patient using statistical health monitoring. |
title_fullStr |
Towards the disease biomarker in an individual patient using statistical health monitoring. |
title_full_unstemmed |
Towards the disease biomarker in an individual patient using statistical health monitoring. |
title_sort |
towards the disease biomarker in an individual patient using statistical health monitoring. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
In metabolomics, identification of complex diseases is often based on application of (multivariate) statistical techniques to the data. Commonly, each disease requires its own specific diagnostic model, separating healthy and diseased individuals, which is not very practical in a diagnostic setting. Additionally, for orphan diseases such models cannot be constructed due to a lack of available data. An alternative approach adapted from industrial process control is proposed in this study: statistical health monitoring (SHM). In SHM the metabolic profile of an individual is compared to that of healthy people in a multivariate manner. Abnormal metabolite concentrations, or abnormal patterns of concentrations, are indicated by the method. Subsequently, this biomarker can be used for diagnosis. A tremendous advantage here is that only data of healthy people is required to construct the model. The method is applicable in current-population based -clinical practice as well as in personalized health applications. In this study, SHM was successfully applied for diagnosis of several orphan diseases as well as detection of metabotypic abnormalities related to diet and drug intake. |
url |
http://europepmc.org/articles/PMC3972152?pdf=render |
work_keys_str_mv |
AT jasperengel towardsthediseasebiomarkerinanindividualpatientusingstatisticalhealthmonitoring AT lionelblanchet towardsthediseasebiomarkerinanindividualpatientusingstatisticalhealthmonitoring AT udofhengelke towardsthediseasebiomarkerinanindividualpatientusingstatisticalhealthmonitoring AT ronawevers towardsthediseasebiomarkerinanindividualpatientusingstatisticalhealthmonitoring AT lutgardemcbuydens towardsthediseasebiomarkerinanindividualpatientusingstatisticalhealthmonitoring |
_version_ |
1725884092307734528 |